2023's Information

2023/04/11

GNI Group summary Q&A from FY2022 AGM

2023/03/31

CBIO filed 10-K

2023/03/16

22nd Annual General Meeting of Shareholders Measures to Prevent the Spread of Covid 19

2023/03/13

Impacts of Silicon Valley Bank closure

2023/03/02

GNI Group summary Q&A from full-year 2022 financial results analyst call and other recent inquiries

2023/01/13

Resuming normal office operations

2023/01/11

2023 New Year Greeting

2023/01/04

FAQ for Our Disclosure on December 27, 2022, “GNI Group and Catalyst Biosciences Signed Agreements to Advance Liver Fibrosis Drug Development”